Monocarboxylate transporters (MCT) 1–4 in cancer and stromal cells as predictors of disease-specific survival in 335 NSCLC patients (univariate analyses; log-rank test). This evidence concerns the gene SLC16A1 and non-small cell lung carcinoma.